Key result
Decreasing cycle length decreased the retrograde effective refractory period of the accessory pathway by 10-60 msec in 13 of 15 assessed patients with Wolff-Parkinson-White syndrome.
Why the study?
What is the effect of changing cycle length on the antegrade and retrograde effective refractory periods of the accessory pathway in patients with Wolff-Parkinson-White syndrome?
Observational (n=47)
What is the effect of changing cycle length on the antegrade and retrograde effective refractory periods of the accessory pathway in patients with Wolff-Parkinson-White syndrome?
Answers are grounded in this paper and cite their sources.
The study demonstrates that the effective refractory periods of accessory pathways in WPW syndrome vary with cycle length, and the shortest antegrade refractory period correlates with the shortest R-R interval during atrial fibrillation.
Antegrade (AERPAP) and retrograde (RERPAP) effective refractory periods of the accessory pathway were measured at multiple cycle lengths in 47 patients with the Wolff-Parkinson-White syndrome. In 20 patients the effect of changing cycle length on AERPAP could be determined. In 12 patients Aerpap decreased by 10-45 msec, in six it increased by 10-35 msec, and in two it was unchanged. In 13 of 15 patients in whom the effect of decreasing cycle length on RERPAP could be assessed, RERPAP decreased by 10-60 msec. In eight patients, the shortest AERPAP correlated well (r equals 0.83) with the shortest R-R interval of consecutive pre-excited beats in atrial fibrillation. However, predominantly normal conduction was observed in six of 28 patients with atrial fibrillation, probably because of concealment in the bypass. Therefore, induction of atrial fibrillation during electrophysiological evaluation may privide additional information. The RERPAP at the cycle length of the arrhythmia was shorter than the cycle length of reciprocating tachycardia in all but one of 21 patients. At the same or comparable cycle lengths, AERPAP was usually greater than RERPAP.
No takes yet. Share an insight, caveat, or question.
Tonkin et al. (1975) conducted an observational in Wolff-Parkinson-White syndrome (n=47). Changing cycle length was evaluated on Antegrade (AERPAP) and retrograde (RERPAP) effective refractory periods. Decreasing cycle length decreased the retrograde effective refractory period of the accessory pathway by 10-60 msec in 13 of 15 assessed patients with Wolff-Parkinson-White syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: